Table 1. Patients’ characteristics.
| Variable | Range | N/Total | % |
|---|---|---|---|
| Age (years) |
< 50 |
18/130 |
14.0 |
| |
50–60 |
66/130 |
50.9 |
| |
> 70 |
46/130 |
35.1 |
| Median age |
64 |
|
|
| Tissue/tumor type |
Normal |
13/130 |
10.0 |
| |
LMP |
13/130 |
10.0 |
| |
High-grade |
52/130 |
40.0 |
| |
OM |
52/130 |
40.0 |
| Stage |
III (A, B and C) |
69/130 |
53.0 |
| |
IV |
30/130 |
23.0 |
| PFS (months)* |
0–6 |
43/99 |
43.4 |
| |
7–24 |
35/99 |
35.4 |
| > 25 | 21/99 | 21.2 |
*
Extended follow-up, including PFS values, were available for 99 patients.